AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
iSpecimen Inc. Raises $1.75 Million Through At-Market Private Placement to Bolster Marketing and Corporate Purposes
ByAinvest
Wednesday, Aug 6, 2025 2:26 pm ET1min read
iSpecimen Inc. (ISPC) closed a $1.75 million private placement, issuing 1.56 million shares of common stock and pre-funded warrants at $1.122 each. Funds will bolster marketing efforts and general corporate purposes. WestPark Capital served as the exclusive placement agent. The transaction closed on August 4, 2025, and details will be disclosed in a Form 8-K filing with the SEC.
iSpecimen Inc. (ISPC), an online marketplace for human biospecimens, has successfully closed a $1.75 million private placement. The company issued 1,559,828 shares of common stock and pre-funded warrants at a price of $1.122 per share, aligning with Nasdaq's at-the-market pricing rules [1].The funds raised will be used to bolster marketing efforts, with $500,000 allocated to marketing and advertising services through IR Agency LLC. The remaining $1.25 million will support working capital and general corporate purposes. WestPark Capital served as the exclusive placement agent for the offering, which closed on August 4, 2025 [2].
iSpecimen's platform connects scientists with healthcare providers, enabling efficient access to necessary biospecimens for medical research and discovery. The company's proprietary, cloud-based technology allows scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations [3].
The private placement was exclusively available to accredited investors and will require subsequent SEC registration for potential resale. Additional details regarding the offering will be available in a Form 8-K filing with the SEC [1].
References:
[1] https://www.globenewswire.com/news-release/2025/08/04/3126989/0/en/iSpecimen-Inc-Announces-Closing-of-Approximately-1-75-Million-Private-Placement-Priced-At-the-Market.html
[2] https://www.gurufocus.com/news/3023707/ispecimen-inc-announces-pricing-of-approximately-175-million-private-placement-priced-atthemarket-ispc-stock-news
[3] https://www.stocktitan.net/news/ISPC/i-specimen-inc-announces-closing-of-approximately-1-75-million-1ebr32zcwmw7.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments

No comments yet